{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T09:20:38Z","timestamp":1788168038951,"version":"build-2803163510"},"reference-count":192,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsmedizin Greifswald"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Fusion transcripts are hybrid RNA molecules generated through genomic rearrangements or RNA-level fusion mechanisms. They represent important molecular features of many cancers and can function as oncogenic drivers, diagnostic biomarkers, prognostic indicators, and therapeutic targets. Since the discovery of the BCR::ABL1 fusion in chronic myeloid leukemia, numerous cancer-associated fusion transcripts have been identified across hematologic malignancies and solid tumors. These fusion events encompass diverse biological mechanisms, including constitutively active kinases, aberrant transcription factors, epigenetic regulators, and non-coding fusion RNAs. This review summarizes current knowledge of the mechanisms underlying fusion transcript formation, including genomic rearrangement-dependent and rearrangement-independent processes, as well as fusion circular RNAs. The functional roles of fusion transcripts in cancer biology and their clinical relevance as diagnostic, prognostic, and predictive biomarkers are discussed. In addition, recent advances in fusion transcript detection and characterization are reviewed, including next-generation sequencing, long-read sequencing, single-cell approaches, artificial intelligence-assisted computational methods, and CRISPR\/Cas9-mediated strategies for functional modeling and functional validation of fusion transcripts. Despite the rapid expansion of fusion transcript catalogs, the biological and clinical significance of most identified fusion events remains incompletely understood. Future progress will depend on integrating advanced sequencing technologies, artificial intelligence-assisted computational prioritization, and systematic functional validation to distinguish clinically actionable fusion transcripts from biologically neutral events. Such multidisciplinary approaches will be essential for translating fusion transcript research into precision oncology and improving cancer diagnosis, patient stratification, and targeted therapy.<\/jats:p>","DOI":"10.1007\/s10238-026-02303-3","type":"journal-article","created":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T07:11:54Z","timestamp":1788160314000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cancer-associated fusion transcripts: mechanisms, functional roles, and clinical implications"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8346-063X","authenticated-orcid":false,"given":"Md Faruq","family":"Hossain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,31]]},"reference":[{"key":"2303_CR1","doi-asserted-by":"publisher","first-page":"D1302","DOI":"10.1093\/nar\/gkae1126","volume":"53","author":"D DSouza","year":"2025","unstructured":"DSouza D, et al ChiTaRS 8.0: the comprehensive database of chimeric transcripts and RNA-seq data with applications in liquid biopsy. Nucleic Acids Res Jan. 2025;53:D1302\u201312. https:\/\/doi.org\/10.1093\/nar\/gkae1126.","journal-title":"Nucleic Acids Res Jan"},{"issue":"8","key":"2303_CR2","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1002\/gcc.23128","volume":"62","author":"J Wang","year":"2023","unstructured":"Wang J, et al. A cloud-based resource for genome coordinate-based exploration and large-scale analysis of chromosome aberrations and gene fusions in cancer. Genes Chromosom Cancer. 2023;62(8):441\u20138. https:\/\/doi.org\/10.1002\/gcc.23128.","journal-title":"Genes Chromosom Cancer"},{"key":"2303_CR3","unstructured":"Mitelman Database Chromosome Aberrations and Gene Fusions in Cancer. Accessed: Jul. 23. 2026. [Online]. Available: https:\/\/mitelmandatabase.isb-cgc.org\/"},{"key":"2303_CR4","unstructured":"OncoKB\u2122 - MSK\u2019s Precision Oncology Knowledge Base. OncoKB\u2122. Accessed: Jul. 23, 2026. [Online]. Available: https:\/\/www.oncokb.org\/"},{"key":"2303_CR5","unstructured":"Cosmic COSMIC-. Catalogue of Somatic Mutations in Cancer. Accessed: Jul. 23, 2026. [Online]. Available: https:\/\/cancer.sanger.ac.uk\/cosmic"},{"key":"2303_CR6","doi-asserted-by":"publisher","unstructured":"Gao Q, et al. Driver Fusions and Their Implications in the Development and Treatment of Human Cancers. Cell Rep. Apr. 2018;23(1):227\u201338. https:\/\/doi.org\/10.1016\/j.celrep.2018.03.050. .e3.","DOI":"10.1016\/j.celrep.2018.03.050"},{"key":"2303_CR7","doi-asserted-by":"publisher","unstructured":"Babiceanu M, et al. Recurrent chimeric fusion RNAs in non-cancer tissues and cells. Nucleic Acids Res. Apr. 2016;44(6):2859\u201372. https:\/\/doi.org\/10.1093\/nar\/gkw032.","DOI":"10.1093\/nar\/gkw032"},{"key":"2303_CR8","doi-asserted-by":"publisher","unstructured":"Gu W, Zhang F, Lupski JR. Mechanisms for human genomic rearrangements. Pathogenetics. Nov. 2008;1(4). https:\/\/doi.org\/10.1186\/1755-8417-1-4.","DOI":"10.1186\/1755-8417-1-4"},{"key":"2303_CR9","doi-asserted-by":"publisher","unstructured":"Yoshioka K, Kusumoto-Matsuo R, Matsuno Y, Ishiai M. Genomic Instability and Cancer Risk Associated with Erroneous DNA Repair, Int J Mol Sci, vol. 22, no. 22, p. 12254, Nov. 2021, https:\/\/doi.org\/10.3390\/ijms222212254","DOI":"10.3390\/ijms222212254"},{"key":"2303_CR10","doi-asserted-by":"publisher","unstructured":"Vijayakrishnan J, et al. Genome-wide association study identifies susceptibility loci for B-cell childhood acute lymphoblastic leukemia. Nat Commun. Apr. 2018;9(1):1340. https:\/\/doi.org\/10.1038\/s41467-018-03178-z.","DOI":"10.1038\/s41467-018-03178-z"},{"key":"2303_CR11","doi-asserted-by":"publisher","unstructured":"Vijayakrishnan J, et al. Identification of four novel associations for B-cell acute lymphoblastic leukaemia risk. Nat Commun. Nov. 2019;10:5348. https:\/\/doi.org\/10.1038\/s41467-019-13069-6.","DOI":"10.1038\/s41467-019-13069-6"},{"key":"2303_CR12","doi-asserted-by":"publisher","unstructured":"Kohaar I et al. Apr., Association of germline genetic variants with TMPRSS2-ERG fusion status in prostate cancer, Oncotarget, vol. 11, no. 15, pp. 1321\u20131333, 2020, https:\/\/doi.org\/10.18632\/oncotarget.27534","DOI":"10.18632\/oncotarget.27534"},{"key":"2303_CR13","doi-asserted-by":"publisher","unstructured":"Gray ZH et al. Oct., Epigenetic balance ensures mechanistic control of MLL amplification and rearrangement, Cell, vol. 186, no. 21, pp. 4528\u20134545.e18, 2023, https:\/\/doi.org\/10.1016\/j.cell.2023.09.009","DOI":"10.1016\/j.cell.2023.09.009"},{"key":"2303_CR14","doi-asserted-by":"publisher","unstructured":"Sigurdson AJ, et al. International study of factors affecting human chromosome translocations. Mutat Res. Apr. 2008;652(2):112\u201321. https:\/\/doi.org\/10.1016\/j.mrgentox.2008.01.005.","DOI":"10.1016\/j.mrgentox.2008.01.005"},{"key":"2303_CR15","doi-asserted-by":"publisher","first-page":"7466","DOI":"10.1093\/nar\/gkm756","volume":"35","author":"V Gorbunova","year":"2007","unstructured":"Gorbunova V, Seluanov A, Mao Z, Hine C. Changes in DNA repair during aging. Nucleic Acids Res. 2007;35:7466\u201374. https:\/\/doi.org\/10.1093\/nar\/gkm756.","journal-title":"Nucleic Acids Res"},{"key":"2303_CR16","doi-asserted-by":"publisher","unstructured":"Vaidya A, Mao Z, Tian X, Spencer B, Seluanov A, Gorbunova V. Knock-in reporter mice demonstrate that DNA repair by non-homologous end joining declines with age. PLoS Genet. Jul. 2014;10(7):e1004511. https:\/\/doi.org\/10.1371\/journal.pgen.1004511.","DOI":"10.1371\/journal.pgen.1004511"},{"key":"2303_CR17","doi-asserted-by":"publisher","unstructured":"Zhang F, Khajavi M, Connolly AM, Towne CF, Batish SD, Lupski JR. The DNA replication FoSTeS\/MMBIR mechanism can generate genomic, genic and exonic complex rearrangements in humans, Nat Genet, vol. 41, no. 7, pp. 849\u2013853, Jul. 2009, https:\/\/doi.org\/10.1038\/ng.399","DOI":"10.1038\/ng.399"},{"key":"2303_CR18","doi-asserted-by":"publisher","unstructured":"Calabrese C, et al. Genomic basis for RNA alterations in cancer. Nature. Feb. 2020;578(7793):129\u201336. https:\/\/doi.org\/10.1038\/s41586-020-1970-0.","DOI":"10.1038\/s41586-020-1970-0"},{"key":"2303_CR19","doi-asserted-by":"publisher","unstructured":"Dorney R, Dhungel BP, Rasko JEJ, Hebbard L, Schmitz U. Recent advances in cancer fusion transcript detection. Brief Bioinform. 2022;24(1). https:\/\/doi.org\/10.1093\/bib\/bbac519.","DOI":"10.1093\/bib\/bbac519"},{"key":"2303_CR20","doi-asserted-by":"publisher","unstructured":"Mohammad T, Zolotovskaia MA, Suntsova MV, Buzdin AA. Cancer fusion transcripts with human non-coding RNAs. Front Oncol. Jun. 2024;14. https:\/\/doi.org\/10.3389\/fonc.2024.1415801.","DOI":"10.3389\/fonc.2024.1415801"},{"key":"2303_CR21","doi-asserted-by":"publisher","unstructured":"Schimmelpfennig C, et al. Characterization and evaluation of gene fusions as a measure of genetic instability and disease prognosis in prostate cancer. BMC Cancer. Jun. 2023;23:575. https:\/\/doi.org\/10.1186\/s12885-023-11019-6.","DOI":"10.1186\/s12885-023-11019-6"},{"key":"2303_CR22","doi-asserted-by":"publisher","unstructured":"Rickman DS, et al. SLC45A3-ELK4 is a Novel and Frequent ETS Fusion Transcript in Prostate Cancer. Cancer Res. Apr. 2009;69(7):2734\u20138. https:\/\/doi.org\/10.1158\/0008-5472.CAN-08-4926.","DOI":"10.1158\/0008-5472.CAN-08-4926"},{"key":"2303_CR23","doi-asserted-by":"publisher","unstructured":"Qin F, et al. Discovery of CTCF-Sensitive Cis-Spliced Fusion RNAs between Adjacent Genes in Human Prostate Cells. PLoS Genet. Feb. 2015;11(2):e1005001. https:\/\/doi.org\/10.1371\/journal.pgen.1005001.","DOI":"10.1371\/journal.pgen.1005001"},{"key":"2303_CR24","doi-asserted-by":"publisher","unstructured":"Zhou JX et al. Mar., Identification of KANSARL as the first cancer predisposition fusion gene specific to the population of European ancestry origin, Oncotarget, vol. 8, no. 31, pp. 50594\u201350607, 2017, https:\/\/doi.org\/10.18632\/oncotarget.16385","DOI":"10.18632\/oncotarget.16385"},{"key":"2303_CR25","doi-asserted-by":"publisher","unstructured":"L\u00f3pez-Nieva P, et al. Detection of novel fusion-transcripts by RNA-Seq in T-cell lymphoblastic lymphoma. Sci Rep. Mar. 2019;9:5179. https:\/\/doi.org\/10.1038\/s41598-019-41675-3.","DOI":"10.1038\/s41598-019-41675-3"},{"key":"2303_CR26","doi-asserted-by":"publisher","unstructured":"Guan X, et al. The KANSL1-ARL17A Fusion Gene Generates Oncogenic chKANSARL and F-circKA RNAs that Synergistically Drive Lung Cancer Progression via a Novel F-circKA\/miR-6860\/chKANSARL Axis. J Biol Chem. Jan. 2026;111170. https:\/\/doi.org\/10.1016\/j.jbc.2026.111170.","DOI":"10.1016\/j.jbc.2026.111170"},{"key":"2303_CR27","doi-asserted-by":"publisher","unstructured":"Guarnerio J, et al. Oncogenic Role of Fusion-circRNAs Derived from Cancer-Associated Chromosomal Translocations. Cell. Apr. 2016;165(2):289\u2013302. https:\/\/doi.org\/10.1016\/j.cell.2016.03.020.","DOI":"10.1016\/j.cell.2016.03.020"},{"key":"2303_CR28","doi-asserted-by":"publisher","unstructured":"Webster J, Mai H, Ly A, Maher C. INTEGRATE-Circ and INTEGRATE-Vis: unbiased detection and visualization of fusion-derived circular RNA. Bioinformatics. Sep. 2023;39(9):btad569. https:\/\/doi.org\/10.1093\/bioinformatics\/btad569.","DOI":"10.1093\/bioinformatics\/btad569"},{"key":"2303_CR29","doi-asserted-by":"publisher","unstructured":"Visci G, Tolomeo D, Agostini A, Traversa D, Macchia G, Storlazzi CT. CircRNAs and Fusion-circRNAs in cancer: New players in an old game. Cell Signal. Nov. 2020;75:109747. https:\/\/doi.org\/10.1016\/j.cellsig.2020.109747.","DOI":"10.1016\/j.cellsig.2020.109747"},{"key":"2303_CR30","doi-asserted-by":"publisher","unstructured":"Xiao J, et al. Circular RNAs Acting as miRNAs\u2019 Sponges and Their Roles in Stem Cells. J Clin Med. May 2022;11(10):2909. https:\/\/doi.org\/10.3390\/jcm11102909.","DOI":"10.3390\/jcm11102909"},{"key":"2303_CR31","doi-asserted-by":"publisher","unstructured":"Das P, Shyamal S, Bhandari V, Panda AC. Antisense Oligonucleotide Pulldown and Silencing of Circular RNA Nfix In Vivo in Neonatal Mouse Lungs, Curr Protoc, vol. 6, no. 3, p. e70339, Mar. 2026, https:\/\/doi.org\/10.1002\/cpz1.70339","DOI":"10.1002\/cpz1.70339"},{"key":"2303_CR32","doi-asserted-by":"publisher","unstructured":"Lee-yow YC, Valbuena RC, Richter CS, Chang HY, Engreitz JM. Junction-targeting designs limit the application of CRISPR-Cas13d in circular RNA perturbation studies. Nucleic Acids Res. Jan. 2026;54(1):gkaf1447. https:\/\/doi.org\/10.1093\/nar\/gkaf1447.","DOI":"10.1093\/nar\/gkaf1447"},{"key":"2303_CR33","doi-asserted-by":"publisher","unstructured":"Nowell PC. The minute chromosome (Phl) in chronic granulocytic leukemia. Blut. Apr. 1962;8:65\u20136. https:\/\/doi.org\/10.1007\/BF01630378.","DOI":"10.1007\/BF01630378"},{"key":"2303_CR34","doi-asserted-by":"publisher","unstructured":"Nowell PC. Discovery of the Philadelphia chromosome: a personal perspective. J Clin Invest. Aug. 2007;117(8):2033\u20135. https:\/\/doi.org\/10.1172\/JCI31771.","DOI":"10.1172\/JCI31771"},{"key":"2303_CR35","doi-asserted-by":"publisher","unstructured":"Rowley JD. Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining, Nature, vol. 243, no. 5405, pp. 290\u2013293, Jun. 1973, https:\/\/doi.org\/10.1038\/243290a0","DOI":"10.1038\/243290a0"},{"key":"2303_CR36","doi-asserted-by":"publisher","unstructured":"Caspersson T, Zech L, Johansson C. Differential binding of alkylating fluorochromes in human chromosomes. Exp Cell Res. Jun. 1970;60(3):315\u20139. https:\/\/doi.org\/10.1016\/0014-4827(70)90523-9.","DOI":"10.1016\/0014-4827(70)90523-9"},{"key":"2303_CR37","doi-asserted-by":"publisher","unstructured":"Rowley JD, Golomb HM, Dougherty C. 15\/17 translocation, a consistent chromosomal change in acute promyelocytic leukaemia, Lancet, vol. 1, no. 8010, pp. 549\u2013550, Mar. 1977, https:\/\/doi.org\/10.1016\/s0140-6736(77)91415-5","DOI":"10.1016\/s0140-6736(77)91415-5"},{"key":"2303_CR38","doi-asserted-by":"publisher","unstructured":"Zhou X et al. Oct., Critical role of tripartite fusion and LBD truncation in certain RARA- and all RARG-related atypical APL, Blood, vol. 144, no. 14, pp. 1471\u20131485, 2024, https:\/\/doi.org\/10.1182\/blood.2024023883","DOI":"10.1182\/blood.2024023883"},{"key":"2303_CR39","doi-asserted-by":"publisher","unstructured":"Wu S et al. Jun., Atypical acute promyelocytic leukemia with tripartite fusion gene PML::RARG::LINE-L2a is resistant to ATRA but sensitive to arsenic-based therapy, Haematologica, vol. 110, no. 12, pp. 3083\u20133087, 2025, https:\/\/doi.org\/10.3324\/haematol.2025.287318","DOI":"10.3324\/haematol.2025.287318"},{"key":"2303_CR40","doi-asserted-by":"publisher","unstructured":"Ptasinska A, et al. Depletion of RUNX1\/ETO in t(8;21) AML cells leads to genome-wide changes in chromatin structure and transcription factor binding. Leukemia. Aug. 2012;26(8):1829\u201341. https:\/\/doi.org\/10.1038\/leu.2012.49.","DOI":"10.1038\/leu.2012.49"},{"key":"2303_CR41","doi-asserted-by":"publisher","unstructured":"Basso K, Frascella E, Zanesco L, Rosolen A. Improved Long-Distance Polymerase Chain Reaction for the Detection of t(8;14)(q24;q32) in Burkitt\u2019s Lymphomas, Am J Pathol, vol. 155, no. 5, pp. 1479\u20131485, Nov. 1999, https:\/\/doi.org\/10.1016\/S0002-9440(10)65463-6","DOI":"10.1016\/S0002-9440(10)65463-6"},{"key":"2303_CR42","doi-asserted-by":"publisher","unstructured":"Jo VY. EWSR1 fusions: Ewing sarcoma and beyond, Cancer Cytopathology, vol. 128, no. 4, pp. 229\u2013231, Apr. 2020, https:\/\/doi.org\/10.1002\/cncy.22239","DOI":"10.1002\/cncy.22239"},{"key":"2303_CR43","doi-asserted-by":"publisher","unstructured":"Linardic CM. PAX3-FOXO1 Fusion Gene in Rhabdomyosarcoma. Cancer Lett. Oct. 2008;270(1):10\u20138. https:\/\/doi.org\/10.1016\/j.canlet.2008.03.035.","DOI":"10.1016\/j.canlet.2008.03.035"},{"key":"2303_CR44","doi-asserted-by":"publisher","unstructured":"G\u00f6ransson M, et al. The myxoid liposarcoma FUS-DDIT3 fusion oncoprotein deregulates NF-\u03baB target genes by interaction with NFKBIZ. Oncogene. Jan. 2009;28(2):270\u20138. https:\/\/doi.org\/10.1038\/onc.2008.378.","DOI":"10.1038\/onc.2008.378"},{"key":"2303_CR45","doi-asserted-by":"publisher","unstructured":"Mertens F, Antonescu CR, Mitelman F. Gene Fusions in Soft Tissue Tumors: Recurrent and Overlapping Pathogenetic Themes. Genes Chromosomes Cancer. Apr. 2016;55(4):291\u2013310. https:\/\/doi.org\/10.1002\/gcc.22335.","DOI":"10.1002\/gcc.22335"},{"key":"2303_CR46","doi-asserted-by":"publisher","unstructured":"Amarante-Mendes GP, Rana A, Datoguia TS, Hamerschlak N, Brumatti G. BCR-ABL1 Tyrosine Kinase Complex Signaling Transduction: Challenges to Overcome Resistance in Chronic Myeloid Leukemia. Pharmaceutics. Jan. 2022;14(1):215. https:\/\/doi.org\/10.3390\/pharmaceutics14010215.","DOI":"10.3390\/pharmaceutics14010215"},{"key":"2303_CR47","doi-asserted-by":"publisher","unstructured":"Ren C, Liu J, Hornicek FJ, Yue B, Duan Z. Advances of SS18-SSX fusion gene in synovial sarcoma: Emerging novel functions and therapeutic potentials, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, vol. 1879, no. 6, p. 189215, Nov. 2024, https:\/\/doi.org\/10.1016\/j.bbcan.2024.189215","DOI":"10.1016\/j.bbcan.2024.189215"},{"key":"2303_CR48","doi-asserted-by":"publisher","unstructured":"Zee BM, Dibona AB, Alekseyenko AA, French CA, Kuroda MI. The Oncoprotein BRD4-NUT Generates Aberrant Histone Modification Patterns. PLoS ONE. Oct. 2016;11(10):e0163820. https:\/\/doi.org\/10.1371\/journal.pone.0163820.","DOI":"10.1371\/journal.pone.0163820"},{"key":"2303_CR49","doi-asserted-by":"publisher","unstructured":"Ma X, et al. The JAZF1-SUZ12 fusion protein disrupts PRC2 complexes and impairs chromatin repression during human endometrial stromal tumorogenesis. Oncotarget. Jan. 2017;8(3):4062\u201378. https:\/\/doi.org\/10.18632\/oncotarget.13270.","DOI":"10.18632\/oncotarget.13270"},{"key":"2303_CR50","doi-asserted-by":"publisher","unstructured":"Affer M et al. Aug., Promiscuous Rearrangements of the MYC Locus Hijack Enhancers and Super-Enhancers to Dysregulate MYC Expression in Multiple Myeloma, Leukemia, vol. 28, no. 8, pp. 1725\u20131735, 2014, https:\/\/doi.org\/10.1038\/leu.2014.70","DOI":"10.1038\/leu.2014.70"},{"key":"2303_CR51","doi-asserted-by":"publisher","unstructured":"Liu Y, et al. Etiology of oncogenic fusions in 5,190 childhood cancers and its clinical and therapeutic implication. Nat Commun. Apr. 2023;14(1):1739. https:\/\/doi.org\/10.1038\/s41467-023-37438-4.","DOI":"10.1038\/s41467-023-37438-4"},{"key":"2303_CR52","doi-asserted-by":"publisher","unstructured":"Darabi S, Zuazo CE, Braxton DR, Eisenberg BL, Demeure MJ. Precision Medicine in a Community Cancer Center: Pan-Cancer DNA\/RNA Sequencing of Tumors Reveals Clinically Relevant Gene Fusions, Biologics, vol. 3, no. 3, pp. 198\u2013208, Sep. 2023, https:\/\/doi.org\/10.3390\/biologics3030011","DOI":"10.3390\/biologics3030011"},{"key":"2303_CR53","doi-asserted-by":"publisher","unstructured":"Liu SV, Nagasaka M, Atz J, Solca F, M\u00fcllauer L. Oncogenic gene fusions in cancer: from biology to therapy. Signal Transduct Target Ther. Apr. 2025;10:111. https:\/\/doi.org\/10.1038\/s41392-025-02161-7.","DOI":"10.1038\/s41392-025-02161-7"},{"key":"2303_CR54","doi-asserted-by":"publisher","unstructured":"Zehir A et al. Jun., Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients, Nat Med, vol. 23, no. 6, pp. 703\u2013713, 2017, https:\/\/doi.org\/10.1038\/nm.4333","DOI":"10.1038\/nm.4333"},{"key":"2303_CR55","doi-asserted-by":"publisher","unstructured":"Lieber MR. Mechanisms of Human Lymphoid Chromosomal Translocations. Nat Rev Cancer. May 2016;16(6):387\u201398. https:\/\/doi.org\/10.1038\/nrc.2016.40.","DOI":"10.1038\/nrc.2016.40"},{"key":"2303_CR56","doi-asserted-by":"publisher","unstructured":"Chen X, Yang W, Roberts CWM, Zhang J. Developmental origins shape the pediatric cancer genome, Nat Rev Cancer, vol. 24, no. 6, pp. 382\u2013398, Jun. 2024, https:\/\/doi.org\/10.1038\/s41568-024-00684-9","DOI":"10.1038\/s41568-024-00684-9"},{"key":"2303_CR57","doi-asserted-by":"publisher","unstructured":"Deininger MWN, Goldman JM, Melo JV. The molecular biology of chronic myeloid leukemia, Blood, vol. 96, no. 10, pp. 3343\u20133356, Nov. 2000, https:\/\/doi.org\/10.1182\/blood.V96.10.3343","DOI":"10.1182\/blood.V96.10.3343"},{"key":"2303_CR58","doi-asserted-by":"publisher","unstructured":"Renneville A et al. Mar., Avadomide Induces Degradation of ZMYM2 Fusion Oncoproteins in Hematologic Malignancies, Blood Cancer Discov, vol. 2, no. 3, pp. 250\u2013265, 2021, https:\/\/doi.org\/10.1158\/2643-3230.BCD-20-0105","DOI":"10.1158\/2643-3230.BCD-20-0105"},{"key":"2303_CR59","doi-asserted-by":"publisher","unstructured":"Shomali W, et al. Comprehensive response criteria for myeloid\/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions: a proposal from the MLN International Working Group. Leukemia. May 2023;37(5):981\u20137. https:\/\/doi.org\/10.1038\/s41375-023-01859-3.","DOI":"10.1038\/s41375-023-01859-3"},{"key":"2303_CR60","doi-asserted-by":"publisher","unstructured":"Persson M, Andr\u00e9n Y, Mark J, Horlings HM, Persson F, Stenman G. Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck, Proc Natl Acad Sci U S A, vol. 106, no. 44, pp. 18740\u201318744, Nov. 2009, https:\/\/doi.org\/10.1073\/pnas.0909114106","DOI":"10.1073\/pnas.0909114106"},{"key":"2303_CR61","doi-asserted-by":"publisher","unstructured":"Jee KJ et al. Feb., Genomic profiles and CRTC1\u2013MAML2 fusion distinguish different subtypes of mucoepidermoid carcinoma, Modern Pathology, vol. 26, no. 2, pp. 213\u2013222, 2013, https:\/\/doi.org\/10.1038\/modpathol.2012.154","DOI":"10.1038\/modpathol.2012.154"},{"key":"2303_CR62","doi-asserted-by":"publisher","unstructured":"Davis IJ et al. Jun., Oncogenic MITF dysregulation in clear cell sarcoma: Defining the MiT family of human cancers, Cancer Cell, vol. 9, no. 6, pp. 473\u2013484, 2006, https:\/\/doi.org\/10.1016\/j.ccr.2006.04.021","DOI":"10.1016\/j.ccr.2006.04.021"},{"key":"2303_CR63","doi-asserted-by":"publisher","unstructured":"Lei Y, Lei Y, Shi X, Wang J. EML4-ALK fusion gene in non-small cell lung cancer. Oncol Lett. Jun. 2022;24(2):277. https:\/\/doi.org\/10.3892\/ol.2022.13397.","DOI":"10.3892\/ol.2022.13397"},{"key":"2303_CR64","doi-asserted-by":"publisher","unstructured":"Qian Y, et al. KIF5B-RET fusion kinase promotes cell growth by multilevel activation of STAT3 in lung cancer. Mol Cancer. Jul. 2014;13(1):176. https:\/\/doi.org\/10.1186\/1476-4598-13-176.","DOI":"10.1186\/1476-4598-13-176"},{"key":"2303_CR65","doi-asserted-by":"publisher","unstructured":"Jones DTW, et al. Tandem Duplication Producing a Novel Oncogenic BRAF Fusion Gene Defines the Majority of Pilocytic Astrocytomas. Cancer Res. Oct. 2008;68(21):8673\u20137. https:\/\/doi.org\/10.1158\/0008-5472.CAN-08-2097.","DOI":"10.1158\/0008-5472.CAN-08-2097"},{"key":"2303_CR66","doi-asserted-by":"publisher","unstructured":"Faulkner C et al. Sep., BRAF Fusion Analysis in Pilocytic Astrocytomas: KIAA1549-BRAF 15\u2009\u2013\u20099 Fusions Are More Frequent in the Midline Than Within the Cerebellum, J Neuropathol Exp Neurol, vol. 74, no. 9, pp. 867\u2013872, 2015, https:\/\/doi.org\/10.1097\/NEN.0000000000000226","DOI":"10.1097\/NEN.0000000000000226"},{"key":"2303_CR67","doi-asserted-by":"publisher","unstructured":"Murati A et al. Sep., PCM1-JAK2 fusion in myeloproliferative disorders and acute erythroid leukemia with t(8;9) translocation, Leukemia, vol. 19, no. 9, pp. 1692\u20131696, 2005, https:\/\/doi.org\/10.1038\/sj.leu.2403879","DOI":"10.1038\/sj.leu.2403879"},{"key":"2303_CR68","doi-asserted-by":"publisher","unstructured":"Masselli E, et al. PCM1-JAK2 Fusion Product Selectively Activates MAP-Kinase Pathway and Fails to Phosphorylate JAK2 and STAT5: Implications for Therapeutic Strategies. Blood. Nov. 2012;120:2858. https:\/\/doi.org\/10.1182\/blood.V120.21.2858.2858.","DOI":"10.1182\/blood.V120.21.2858.2858"},{"key":"2303_CR69","doi-asserted-by":"publisher","unstructured":"Tognon C et al. Nov., Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma, Cancer Cell, vol. 2, no. 5, pp. 367\u2013376, 2002, https:\/\/doi.org\/10.1016\/s1535-6108(02)00180-0","DOI":"10.1016\/s1535-6108(02)00180-0"},{"key":"2303_CR70","doi-asserted-by":"publisher","unstructured":"Knezevich SR, McFadden DE, Tao W, Lim JF, Sorensen PHB. A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma, Nat Genet, vol. 18, no. 2, pp. 184\u2013187, Feb. 1998, https:\/\/doi.org\/10.1038\/ng0298-184","DOI":"10.1038\/ng0298-184"},{"key":"2303_CR71","doi-asserted-by":"publisher","unstructured":"Asahina M et al. Nov., Identification of CTNNB1-PLAG1 gene rearrangement in a patient with pulmonary pleomorphic adenoma, Virchows Arch, vol. 477, no. 5, pp. 739\u2013742, 2020, https:\/\/doi.org\/10.1007\/s00428-020-02810-y","DOI":"10.1007\/s00428-020-02810-y"},{"key":"2303_CR72","doi-asserted-by":"publisher","unstructured":"Jun HJ, Johnson H, Bronson RT, de Feraudy S, White F, Charest A. The Oncogenic Lung Cancer Fusion Kinase CD74-ROS Activates a Novel Invasiveness Pathway Through E-Syt1 Phosphorylation. Cancer Res. Aug. 2012;72(15):3764\u201374. https:\/\/doi.org\/10.1158\/0008-5472.CAN-11-3990.","DOI":"10.1158\/0008-5472.CAN-11-3990"},{"key":"2303_CR73","doi-asserted-by":"publisher","unstructured":"Swart LE, Heidenreich O. The RUNX1\/RUNX1T1 network: translating insights into therapeutic options. Exp Hematol. Feb. 2021;94:1\u201310. https:\/\/doi.org\/10.1016\/j.exphem.2020.11.005.","DOI":"10.1016\/j.exphem.2020.11.005"},{"key":"2303_CR74","doi-asserted-by":"publisher","unstructured":"Liquori A, Iba\u00f1ez M, Sargas C, Sanz M\u00c1, Barrag\u00e1n E, Cervera J. Acute Promyelocytic Leukemia: A Constellation of Molecular Events around a Single PML-RARA Fusion Gene. Cancers (Basel). Mar. 2020;12(3):624. https:\/\/doi.org\/10.3390\/cancers12030624.","DOI":"10.3390\/cancers12030624"},{"key":"2303_CR75","doi-asserted-by":"publisher","unstructured":"Jakobczyk H, et al. ETV6-RUNX1 and RUNX1 directly regulate RAG1 expression: one more step in the understanding of childhood B-cell acute lymphoblastic leukemia leukemogenesis. Leukemia. Feb. 2022;36(2):549\u201354. https:\/\/doi.org\/10.1038\/s41375-021-01409-9.","DOI":"10.1038\/s41375-021-01409-9"},{"key":"2303_CR76","doi-asserted-by":"publisher","unstructured":"Torrano V, Procter J, Cardus P, Greaves M, Ford AM. ETV6-RUNX1 promotes survival of early B lineage progenitor cells via a dysregulated erythropoietin receptor, Blood, vol. 118, no. 18, pp. 4910\u20134918, Nov. 2011, https:\/\/doi.org\/10.1182\/blood-2011-05-354266","DOI":"10.1182\/blood-2011-05-354266"},{"key":"2303_CR77","doi-asserted-by":"publisher","unstructured":"Matsukawa T, et al. NUP98::Nsd1 and FLT3-ITD collaborate to generate acute myeloid leukemia. Leukemia. Jul. 2023;37(7):1545\u20138. https:\/\/doi.org\/10.1038\/s41375-023-01913-0.","DOI":"10.1038\/s41375-023-01913-0"},{"key":"2303_CR78","unstructured":"Jaju RJ et al. Jul., A new recurrent translocation, t(5;11)(q35;p15.5), associated with del(5q) in childhood acute myeloid leukemia. The UK Cancer Cytogenetics Group (UKCCG), Blood, vol. 94, no. 2, pp. 773\u2013780, 1999."},{"key":"2303_CR79","doi-asserted-by":"publisher","unstructured":"Okamoto K, et al. The Nup98::Nsd1 fusion gene induces CD123 expression in 32D cells. Int J Hematol. Aug. 2023;118(2):277\u201387. https:\/\/doi.org\/10.1007\/s12185-023-03612-z.","DOI":"10.1007\/s12185-023-03612-z"},{"key":"2303_CR80","doi-asserted-by":"publisher","unstructured":"Liu PP, et al. Identification of the chimeric protein product of the CBFB-MYH11 fusion gene in inv(16) leukemia cells. Genes Chromosom Cancer. 1996;16(2):77\u201387. https:\/\/doi.org\/10.1002\/(SICI)1098-2264(199606)16:2%3C77::AID-GCC1%3E3.0.CO;2-#.","DOI":"10.1002\/(SICI)1098-2264(199606)16:2%3C77::AID-GCC1%3E3.0.CO;2-#"},{"key":"2303_CR81","doi-asserted-by":"publisher","first-page":"123253","DOI":"10.1155\/2012\/123253","volume":"2012","author":"JD Pearson","year":"2012","unstructured":"Pearson JD, Lee JKH, Bacani JTC, Lai R, Ingham RJ. NPM-ALK: The Prototypic Member of a Family of Oncogenic Fusion Tyrosine Kinases. J Signal Transduct. 2012;2012:123253. https:\/\/doi.org\/10.1155\/2012\/123253.","journal-title":"J Signal Transduct"},{"key":"2303_CR82","doi-asserted-by":"publisher","unstructured":"Zamo A, et al. Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death. Oncogene. Feb. 2002;21(7):1038\u201347. https:\/\/doi.org\/10.1038\/sj.onc.1205152.","DOI":"10.1038\/sj.onc.1205152"},{"key":"2303_CR83","doi-asserted-by":"publisher","unstructured":"McBride MJ, et al. The SS18-SSX Fusion Oncoprotein Hijacks BAF Complex Targeting and Function to Drive Synovial Sarcoma. Cancer Cell. Jun. 2018;33(6):1128\u201341. https:\/\/doi.org\/10.1016\/j.ccell.2018.05.002. .e7.","DOI":"10.1016\/j.ccell.2018.05.002"},{"key":"2303_CR84","doi-asserted-by":"publisher","unstructured":"Tomlins SA et al. Oct., Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer, Science, vol. 310, no. 5748, pp. 644\u2013648, 2005, https:\/\/doi.org\/10.1126\/science.1117679","DOI":"10.1126\/science.1117679"},{"key":"2303_CR85","doi-asserted-by":"publisher","unstructured":"Klezovitch O et al. Feb., A causal role for ERG in neoplastic transformation of prostate epithelium, Proceedings of the National Academy of Sciences, vol. 105, no. 6, pp. 2105\u20132110, 2008, https:\/\/doi.org\/10.1073\/pnas.0711711105","DOI":"10.1073\/pnas.0711711105"},{"key":"2303_CR86","doi-asserted-by":"publisher","unstructured":"Hrzenjak A. JAZF1\/SUZ12 gene fusion in endometrial stromal sarcomas. Orphanet J Rare Dis. Feb. 2016;11:15. https:\/\/doi.org\/10.1186\/s13023-016-0400-8.","DOI":"10.1186\/s13023-016-0400-8"},{"key":"2303_CR87","unstructured":"French CA, Miyoshi I, Kubonishi I, Grier HE, Perez-Atayde AR, Fletcher JA. BRD4-NUT fusion oncogene: a novel mechanism in aggressive carcinoma. Cancer Res. Jan. 2003;63(2):304\u20137."},{"key":"2303_CR88","doi-asserted-by":"publisher","unstructured":"Suzuki K, et al. MEF2D-BCL9 Fusion Gene Is Associated With High-Risk Acute B-Cell Precursor Lymphoblastic Leukemia in Adolescents. J Clin Oncol. Oct. 2016;34:3451\u20139. https:\/\/doi.org\/10.1200\/JCO.2016.66.5547.","DOI":"10.1200\/JCO.2016.66.5547"},{"key":"2303_CR89","doi-asserted-by":"publisher","unstructured":"Frattini V et al. Oct., The integrated landscape of driver genomic alterations in glioblastoma, Nat Genet, vol. 45, no. 10, pp. 1141\u20131149, 2013, https:\/\/doi.org\/10.1038\/ng.2734","DOI":"10.1038\/ng.2734"},{"key":"2303_CR90","doi-asserted-by":"publisher","unstructured":"Bao Z-S et al. Nov., RNA-seq of 272 gliomas revealed a novel, recurrent PTPRZ1-MET fusion transcript in secondary glioblastomas, Genome Res., vol. 24, no. 11, pp. 1765\u20131773, 2014, https:\/\/doi.org\/10.1101\/gr.165126.113","DOI":"10.1101\/gr.165126.113"},{"issue":"13","key":"2303_CR91","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1016\/j.febslet.2015.04.032","volume":"589","author":"H-M Chen","year":"2015","unstructured":"Chen H-M, et al. Enhanced expression and phosphorylation of the MET oncoprotein by glioma-specific PTPRZ1\u2013MET fusions. FEBS Lett. 2015;589(13):1437\u201343. https:\/\/doi.org\/10.1016\/j.febslet.2015.04.032.","journal-title":"FEBS Lett"},{"key":"2303_CR92","doi-asserted-by":"publisher","unstructured":"Graham RP et al. Jun., DNAJB1-PRKACA is specific for fibrolamellar carcinoma, Modern Pathology, vol. 28, no. 6, pp. 822\u2013829, 2015, https:\/\/doi.org\/10.1038\/modpathol.2015.4","DOI":"10.1038\/modpathol.2015.4"},{"key":"2303_CR93","doi-asserted-by":"publisher","unstructured":"Gritti I, et al. DNAJB1-PRKACA Fusion Drives Fibrolamellar Liver Cancer through Impaired SIK Signaling and CRTC2\/p300-Mediated Transcriptional Reprogramming. Cancer Discov. Feb. 2025;15(2):382\u2013400. https:\/\/doi.org\/10.1158\/2159-8290.CD-24-0634.","DOI":"10.1158\/2159-8290.CD-24-0634"},{"key":"2303_CR94","doi-asserted-by":"publisher","unstructured":"Wang L, et al. Identification of a Novel, Recurrent HEY1-NCOA2 Fusion in Mesenchymal Chondrosarcoma based on a Genome-wide Screen of Exon-level Expression Data. Genes Chromosomes Cancer. Feb. 2012;51(2):127\u201339. https:\/\/doi.org\/10.1002\/gcc.20937.","DOI":"10.1002\/gcc.20937"},{"issue":"5","key":"2303_CR95","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1002\/path.5899","volume":"257","author":"W Qi","year":"2022","unstructured":"Qi W, et al. Genomic profiling identifies genes and pathways dysregulated by HEY1\u2013NCOA2 fusion and shines a light on mesenchymal chondrosarcoma tumorigenesis. J Pathol. 2022;257(5):579\u201392. https:\/\/doi.org\/10.1002\/path.5899.","journal-title":"J Pathol"},{"key":"2303_CR96","doi-asserted-by":"publisher","unstructured":"Xie Z, Tang Y, Su X, Cao J, Zhang Y, Li H. PAX3-FOXO1 escapes miR-495 regulation during muscle differentiation, RNA Biol, vol. 16, no. 1, pp. 144\u2013153, Jan. 2019, https:\/\/doi.org\/10.1080\/15476286.2018.1564464","DOI":"10.1080\/15476286.2018.1564464"},{"key":"2303_CR97","unstructured":"Kowarz E, Merkens J, Karas M, Dingermann T, Marschalek R. Premature transcript termination, trans-splicing and DNA repair: a vicious path to cancer, Am J Blood Res, vol. 1, no. 1, pp. 1\u201312, Apr. 2011."},{"key":"2303_CR98","doi-asserted-by":"publisher","unstructured":"Li H, Wang J, Mor G, Sklar J. A neoplastic gene fusion mimics trans-splicing of RNAs in normal human cells, Science, vol. 321, no. 5894, pp. 1357\u20131361, Sep. 2008, https:\/\/doi.org\/10.1126\/science.1156725","DOI":"10.1126\/science.1156725"},{"key":"2303_CR99","doi-asserted-by":"publisher","unstructured":"Umbreen S, et al. COMMD3:BMI1 Fusion and COMMD3 Protein Regulate C-MYC Transcription: Novel Therapeutic Target for Metastatic Prostate Cancer. Mol Cancer Ther. Nov. 2019;18(11):2111\u201323. https:\/\/doi.org\/10.1158\/1535-7163.MCT-19-0150.","DOI":"10.1158\/1535-7163.MCT-19-0150"},{"key":"2303_CR100","doi-asserted-by":"publisher","unstructured":"Ren S, et al. RNA-seq analysis of prostate cancer in the Chinese population identifies recurrent gene fusions, cancer-associated long noncoding RNAs and aberrant alternative splicings. Cell Res. May 2012;22(5):806\u201321. https:\/\/doi.org\/10.1038\/cr.2012.30.","DOI":"10.1038\/cr.2012.30"},{"key":"2303_CR101","doi-asserted-by":"publisher","unstructured":"Zang ZJ, et al. Genetic and Structural Variation in the Gastric Cancer Kinome Revealed through Targeted Deep Sequencing. Cancer Res. Jan. 2011;71(1):29\u201339. https:\/\/doi.org\/10.1158\/0008-5472.CAN-10-1749.","DOI":"10.1158\/0008-5472.CAN-10-1749"},{"key":"2303_CR102","doi-asserted-by":"publisher","unstructured":"Varley KE, et al. Recurrent read-through fusion transcripts in breast cancer. Breast Cancer Res Treat. Jul. 2014;146(2):287\u201397. https:\/\/doi.org\/10.1007\/s10549-014-3019-2.","DOI":"10.1007\/s10549-014-3019-2"},{"key":"2303_CR103","doi-asserted-by":"publisher","unstructured":"Wu P, et al. The Landscape and Implications of Chimeric RNAs in Cervical Cancer. eBioMedicine. Oct. 2018;37:158\u201367. https:\/\/doi.org\/10.1016\/j.ebiom.2018.10.059.","DOI":"10.1016\/j.ebiom.2018.10.059"},{"key":"2303_CR104","doi-asserted-by":"publisher","unstructured":"Wu K, et al. Circular RNA F-circSR derived from SLC34A2-ROS1 fusion gene promotes cell migration in non-small cell lung cancer. Mol Cancer. May 2019;18:98. https:\/\/doi.org\/10.1186\/s12943-019-1028-9.","DOI":"10.1186\/s12943-019-1028-9"},{"issue":"1","key":"2303_CR105","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1007\/s13577-021-00628-7","volume":"35","author":"Y Huo","year":"2022","unstructured":"Huo Y, et al. F-circEA1 regulates cell proliferation and apoptosis through ALK downstream signaling pathway in non-small cell lung cancer. Hum Cell. 2022;35(1):260\u201370. https:\/\/doi.org\/10.1007\/s13577-021-00628-7.","journal-title":"Hum Cell"},{"key":"2303_CR106","doi-asserted-by":"publisher","unstructured":"Tan S, et al. Circular RNA F-circEA-2a derived from EML4-ALK fusion gene promotes cell migration and invasion in non-small cell lung cancer. Mol Cancer. Sep. 2018;17:138. https:\/\/doi.org\/10.1186\/s12943-018-0887-9.","DOI":"10.1186\/s12943-018-0887-9"},{"key":"2303_CR107","doi-asserted-by":"publisher","unstructured":"Pan Y, et al. CircBA9.3 supports the survival of leukaemic cells by up-regulating c-ABL1 or BCR-ABL1 protein levels. Blood Cells Mol Dis. Nov. 2018;73:38\u201344. https:\/\/doi.org\/10.1016\/j.bcmd.2018.09.002.","DOI":"10.1016\/j.bcmd.2018.09.002"},{"key":"2303_CR108","doi-asserted-by":"publisher","unstructured":"Tan Y, Huang Z, Wang X, Dai H, Jiang G, Feng W. A novel fusion circular RNA F-circBA1 derived from the BCR-ABL fusion gene displayed an oncogenic role in chronic myeloid leukemia cells. Bioengineered, 12, 1, pp. 4816\u201327, https:\/\/doi.org\/10.1080\/21655979.2021.1957749","DOI":"10.1080\/21655979.2021.1957749"},{"key":"2303_CR109","doi-asserted-by":"publisher","unstructured":"Villiers W, et al. Multi-omics and machine learning reveal context-specific gene regulatory activities of PML::RARA in acute promyelocytic leukemia. Nat Commun. Feb. 2023;14:724. https:\/\/doi.org\/10.1038\/s41467-023-36262-0.","DOI":"10.1038\/s41467-023-36262-0"},{"key":"2303_CR110","doi-asserted-by":"publisher","unstructured":"Dupuy M, et al. Ewing sarcoma from molecular biology to the clinic. Front Cell Dev Biol. Sep. 2023;11. https:\/\/doi.org\/10.3389\/fcell.2023.1248753.","DOI":"10.3389\/fcell.2023.1248753"},{"key":"2303_CR111","doi-asserted-by":"publisher","unstructured":"Babin L, Andraos E, Fuchs S, Pyronnet S, Brunet E, Meggetto F. From circRNAs to fusion circRNAs in hematological malignancies. JCI Insight, 6, 21, p. e151513, https:\/\/doi.org\/10.1172\/jci.insight.151513","DOI":"10.1172\/jci.insight.151513"},{"issue":"1","key":"2303_CR112","first-page":"171","volume":"1","author":"C O\u2019Connor","year":"2008","unstructured":"O\u2019Connor C. Fluorescence in situ hybridization (FISH). Nat Educ. 2008;1(1):171.","journal-title":"Nat Educ"},{"key":"2303_CR113","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/cjp2.64","volume":"3","author":"L Cheng","year":"2017","unstructured":"Cheng L, Zhang S, Wang L, MacLennan GT, Davidson DD. Fluorescence in situ hybridization in surgical pathology: principles and applications. J Pathol Clin Res. 2017;3:73\u201399. https:\/\/doi.org\/10.1002\/cjp2.64. no. 2.","journal-title":"J Pathol Clin Res"},{"key":"2303_CR114","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1042\/CS20050086","volume":"109","author":"SA Bustin","year":"2005","unstructured":"Bustin SA, Mueller R. Real-time reverse transcription PCR (qRT-PCR) and its potential use in clinical diagnosis. Clin Sci (Lond). 2005;109:365\u201379. https:\/\/doi.org\/10.1042\/CS20050086. no. 4.","journal-title":"Clin Sci (Lond)"},{"key":"2303_CR115","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/s0065-2423(05)40006-2","volume":"40","author":"B Kaltenboeck","year":"2005","unstructured":"Kaltenboeck B, Wang C. Advances in real-time PCR: application to clinical laboratory diagnostics. Adv Clin Chem. 2005;40:219\u201359. https:\/\/doi.org\/10.1016\/s0065-2423(05)40006-2.","journal-title":"Adv Clin Chem"},{"key":"2303_CR116","doi-asserted-by":"publisher","unstructured":"Zheng Z, et al. Anchored multiplex PCR for targeted next-generation sequencing. Nat Med. Dec. 2014;20(12):1479\u201384. https:\/\/doi.org\/10.1038\/nm.3729.","DOI":"10.1038\/nm.3729"},{"key":"2303_CR117","doi-asserted-by":"publisher","unstructured":"Wallen ZD, et al. RNA hybrid-capture next-generation sequencing has high sensitivity in identifying known and less characterized oncogenic and likely oncogenic NTRK fusions in a real-world standard-of-care setting. Front Genet. May 2025;16:1550706. https:\/\/doi.org\/10.3389\/fgene.2025.1550706.","DOI":"10.3389\/fgene.2025.1550706"},{"key":"2303_CR118","doi-asserted-by":"publisher","unstructured":"Skotheim RI, et al. A universal assay for detection of oncogenic fusion transcripts by oligo microarray analysis. Mol Cancer. 2009;8(5). https:\/\/doi.org\/10.1186\/1476-4598-8-5.","DOI":"10.1186\/1476-4598-8-5"},{"key":"2303_CR119","doi-asserted-by":"publisher","unstructured":"Coccaro N, Tota G, Anelli L, Zagaria A, Specchia G, Albano F. Digital PCR: A Reliable Tool for Analyzing and Monitoring Hematologic Malignancies. Int J Mol Sci. 2020;21(9). https:\/\/doi.org\/10.3390\/ijms21093141.","DOI":"10.3390\/ijms21093141"},{"key":"2303_CR120","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00428-023-03707-2","volume":"484","author":"AC Mackinnon","year":"2024","unstructured":"Mackinnon AC, Chandrashekar DS, Suster DI. Molecular pathology as basis for timely cancer diagnosis and therapy. Virchows Arch. 2024;484:155\u201368. https:\/\/doi.org\/10.1007\/s00428-023-03707-2. no. 2.","journal-title":"Virchows Arch"},{"key":"2303_CR121","doi-asserted-by":"publisher","first-page":"102649","DOI":"10.1016\/j.ctrv.2023.102649","volume":"122","author":"A Stenzinger","year":"2024","unstructured":"Stenzinger A, et al. Molecular profiling in cholangiocarcinoma: A practical guide to next-generation sequencing. Cancer Treat Rev. 2024;122:102649. https:\/\/doi.org\/10.1016\/j.ctrv.2023.102649.","journal-title":"Cancer Treat Rev"},{"key":"2303_CR122","doi-asserted-by":"publisher","unstructured":"Bagger FO, et al. Whole genome sequencing in clinical practice. BMC Med Genomics. Jan. 2024;17:39. https:\/\/doi.org\/10.1186\/s12920-024-01795-w.","DOI":"10.1186\/s12920-024-01795-w"},{"key":"2303_CR123","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1182\/blood.2022016954","volume":"141","author":"I Iacobucci","year":"2023","unstructured":"Iacobucci I, Witkowski MT, Mullighan CG. Single-cell analysis of acute lymphoblastic and lineage-ambiguous leukemia: approaches and molecular insights. Blood. 2023;141:356\u201368. https:\/\/doi.org\/10.1182\/blood.2022016954. no. 4.","journal-title":"Blood"},{"key":"2303_CR124","doi-asserted-by":"publisher","unstructured":"Paas-Oliveros E, Hern\u00e1ndez-Lemus E, de Anda-J\u00e1uregui G. Computational single cell oncology: state of the art. Front Genet. 2023;14. https:\/\/doi.org\/10.3389\/fgene.2023.1256991.","DOI":"10.3389\/fgene.2023.1256991"},{"key":"2303_CR125","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.pathol.2023.10.015","volume":"56","author":"A Patton","year":"2024","unstructured":"Patton A, Dermawan JK. Current updates in sarcoma biomarker discovery: emphasis on next-generation sequencing-based methods. Pathology. 2024;56:274\u201382. https:\/\/doi.org\/10.1016\/j.pathol.2023.10.015. no. 2.","journal-title":"Pathology"},{"key":"2303_CR126","doi-asserted-by":"publisher","unstructured":"ALLMER J. Deep learning in bioinformatics. Turk J Biol, 47, 6, pp. 366\u201382, https:\/\/doi.org\/10.55730\/1300-0152.2671","DOI":"10.55730\/1300-0152.2671"},{"key":"2303_CR127","doi-asserted-by":"publisher","unstructured":"LeCun Y, Bengio Y, Hinton G. Deep learning. Nature. May 2015;521(7553):436\u201344. https:\/\/doi.org\/10.1038\/nature14539.","DOI":"10.1038\/nature14539"},{"key":"2303_CR128","doi-asserted-by":"publisher","unstructured":"Jeong CB, Cho H, Park D. Deep learning application for genomic data analysis. BMB Rep. Jan. 2026;59(1):60\u20138. https:\/\/doi.org\/10.5483\/BMBRep.2025-0020.","DOI":"10.5483\/BMBRep.2025-0020"},{"key":"2303_CR129","doi-asserted-by":"publisher","unstructured":"Park J, et al. Accurate somatic small variant discovery for multiple sequencing technologies with DeepSomatic. Nat Biotechnol. Oct. 2025;1\u201310. https:\/\/doi.org\/10.1038\/s41587-025-02839-x.","DOI":"10.1038\/s41587-025-02839-x"},{"key":"2303_CR130","doi-asserted-by":"publisher","unstructured":"Kim P, Tan H, Liu J, Yang M, Zhou X. FusionAI: Predicting fusion breakpoint from DNA sequence with deep learning. iScience. Oct. 2021;24(10):103164. https:\/\/doi.org\/10.1016\/j.isci.2021.103164.","DOI":"10.1016\/j.isci.2021.103164"},{"key":"2303_CR131","doi-asserted-by":"publisher","unstructured":"Tran TN, et al. AI cancer driver mutation predictions are valid in real-world data. Nat Commun. Sep. 2025;16(1):8509. https:\/\/doi.org\/10.1038\/s41467-025-63461-8.","DOI":"10.1038\/s41467-025-63461-8"},{"key":"2303_CR132","doi-asserted-by":"publisher","unstructured":"Haas BJ et al. STAR-Fusion: Fast and Accurate Fusion Transcript Detection from RNA-Seq, Mar. 24, 2017, bioRxiv. https:\/\/doi.org\/10.1101\/120295","DOI":"10.1101\/120295"},{"key":"2303_CR133","doi-asserted-by":"publisher","unstructured":"Uhrig S et al. Mar., Accurate and efficient detection of gene fusions from RNA sequencing data, Genome Res, vol. 31, no. 3, pp. 448\u2013460, 2021, https:\/\/doi.org\/10.1101\/gr.257246.119","DOI":"10.1101\/gr.257246.119"},{"key":"2303_CR134","doi-asserted-by":"publisher","unstructured":"Ball M, et al. Diagnostic whole transcriptome sequencing in a series of 1233 FFPE solid tumor samples. Br J Cancer. Jan. 2026;1\u201310. https:\/\/doi.org\/10.1038\/s41416-025-03307-8.","DOI":"10.1038\/s41416-025-03307-8"},{"key":"2303_CR135","doi-asserted-by":"publisher","unstructured":"Aulakh S et al. Nov., Fusion transcriptome landscape in glioblastoma: Incidence and therapeutic implications, Neurooncol Adv, vol. 8, no. 1, p. vdaf238, 2025, https:\/\/doi.org\/10.1093\/noajnl\/vdaf238","DOI":"10.1093\/noajnl\/vdaf238"},{"key":"2303_CR136","doi-asserted-by":"publisher","unstructured":"Capone I et al. Oct., Targeted RNA-sequencing analysis for fusion transcripts detection in tumor diagnostics: assessment of bioinformatic tools reliability in FFPE samples, Explor Target Antitumor Ther., vol. 3, no. 5, pp. 582\u2013597, 2022, https:\/\/doi.org\/10.37349\/etat.2022.00102","DOI":"10.37349\/etat.2022.00102"},{"key":"2303_CR137","doi-asserted-by":"publisher","unstructured":"Maruta R et al. Sep., Case Report: Structurally Rare EML4-ALK Identified by Next Generation Sequencing in a Patient with NSCLC with Bilateral Ovarian Metastases, Onco Targets Ther, vol. 17, pp. 777\u2013783, 2024, https:\/\/doi.org\/10.2147\/OTT.S474134","DOI":"10.2147\/OTT.S474134"},{"key":"2303_CR138","doi-asserted-by":"publisher","unstructured":"Ament IH, DeBruyne N, Wang F, Lin L. Long-read RNA sequencing: A transformative technology for exploring transcriptome complexity in human diseases, Mol Ther, vol. 33, no. 3, pp. 883\u2013894, Mar. 2025, https:\/\/doi.org\/10.1016\/j.ymthe.2024.11.025","DOI":"10.1016\/j.ymthe.2024.11.025"},{"key":"2303_CR139","doi-asserted-by":"publisher","unstructured":"Qin Q et al. Feb., CTAT-LR-fusion: accurate fusion transcript identification from long and short read isoform sequencing at bulk or single cell resolution, bioRxiv, p. 2024.02.24.581862, 2024, https:\/\/doi.org\/10.1101\/2024.02.24.581862","DOI":"10.1101\/2024.02.24.581862"},{"key":"2303_CR140","doi-asserted-by":"publisher","unstructured":"Li Y, Heavican TB, Vellichirammal NN, Iqbal J, Guda C. ChimeRScope: a novel alignment-free algorithm for fusion transcript prediction using paired-end RNA-Seq data. Nucleic Acids Res. Jul. 2017;45(13):e120. https:\/\/doi.org\/10.1093\/nar\/gkx315.","DOI":"10.1093\/nar\/gkx315"},{"key":"2303_CR141","doi-asserted-by":"publisher","unstructured":"Kim C-Y et al. Aug., FusionPro, a Versatile Proteogenomic Tool for Identification of Novel Fusion Transcripts and Their Potential Translation Products in Cancer Cells, Mol Cell Proteomics, vol. 18, no. 8, pp. 1651\u20131668, 2019, https:\/\/doi.org\/10.1074\/mcp.RA119.001456","DOI":"10.1074\/mcp.RA119.001456"},{"key":"2303_CR142","doi-asserted-by":"publisher","unstructured":"Haas BJ, Dobin A, Li B, Stransky N, Pochet N, Regev A. Accuracy assessment of fusion transcript detection via read-mapping and de novo fusion transcript assembly-based methods. Genome Biol. Oct. 2019;20:213. https:\/\/doi.org\/10.1186\/s13059-019-1842-9.","DOI":"10.1186\/s13059-019-1842-9"},{"key":"2303_CR143","doi-asserted-by":"publisher","unstructured":"Nicorici D et al. FusionCatcher \u2013 a tool for finding somatic fusion genes in paired-end RNA-sequencing data, Nov. 19, 2014, bioRxiv. https:\/\/doi.org\/10.1101\/011650","DOI":"10.1101\/011650"},{"key":"2303_CR144","doi-asserted-by":"publisher","unstructured":"Tian L, et al. CICERO: a versatile method for detecting complex and diverse driver fusions using cancer RNA sequencing data. Genome Biol. May 2020;21(1):126. https:\/\/doi.org\/10.1186\/s13059-020-02043-x.","DOI":"10.1186\/s13059-020-02043-x"},{"key":"2303_CR145","doi-asserted-by":"publisher","unstructured":"Apostolides M et al. Oct., MetaFusion: a high-confidence metacaller for filtering and prioritizing RNA-seq gene fusion candidates, Bioinformatics, vol. 37, no. 19, pp. 3144\u20133151, 2021, https:\/\/doi.org\/10.1093\/bioinformatics\/btab249","DOI":"10.1093\/bioinformatics\/btab249"},{"key":"2303_CR146","doi-asserted-by":"publisher","unstructured":"Davidson NM, et al. JAFFAL: detecting fusion genes with long-read transcriptome sequencing. Genome Biol. Jan. 2022;23:10. https:\/\/doi.org\/10.1186\/s13059-021-02588-5.","DOI":"10.1186\/s13059-021-02588-5"},{"key":"2303_CR147","doi-asserted-by":"publisher","unstructured":"Chen X et al. Apr., Manta: rapid detection of structural variants and indels for germline and cancer sequencing applications, Bioinformatics, vol. 32, no. 8, pp. 1220\u20131222, 2016, https:\/\/doi.org\/10.1093\/bioinformatics\/btv710","DOI":"10.1093\/bioinformatics\/btv710"},{"key":"2303_CR148","doi-asserted-by":"publisher","unstructured":"Thomson A, Rehn J, Yeung D, Breen J, White D. Deciphering IGH rearrangement complexity and detection strategies in acute lymphoblastic leukaemia. NPJ Precis Oncol. Apr. 2025;9:99. https:\/\/doi.org\/10.1038\/s41698-025-00887-9.","DOI":"10.1038\/s41698-025-00887-9"},{"key":"2303_CR149","doi-asserted-by":"publisher","unstructured":"Li T, et al. CRISPR\/Cas9 therapeutics: progress and prospects. Sig Transduct Target Ther. Jan. 2023;8(1):1\u201323. https:\/\/doi.org\/10.1038\/s41392-023-01309-7.","DOI":"10.1038\/s41392-023-01309-7"},{"key":"2303_CR150","doi-asserted-by":"publisher","unstructured":"Liu Y, Wu W, Cai C, Zhang H, Shen H, Han Y. Patient-derived xenograft models in cancer therapy: technologies and applications. Sig Transduct Target Ther. Apr. 2023;8(1):160. https:\/\/doi.org\/10.1038\/s41392-023-01419-2.","DOI":"10.1038\/s41392-023-01419-2"},{"key":"2303_CR151","doi-asserted-by":"publisher","unstructured":"Mulat M, et al. Application of artificial intelligence in microbial drug discovery: Unlocking new frontiers in biotechnology. J Microbiol Methods. Oct. 2025;237:107232. https:\/\/doi.org\/10.1016\/j.mimet.2025.107232.","DOI":"10.1016\/j.mimet.2025.107232"},{"key":"2303_CR152","doi-asserted-by":"publisher","unstructured":"Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier E. A Programmable Dual-RNA\u2013Guided DNA Endonuclease in Adaptive Bacterial Immunity. Science. Aug. 2012;337(6096):816\u201321. https:\/\/doi.org\/10.1126\/science.1225829.","DOI":"10.1126\/science.1225829"},{"key":"2303_CR153","doi-asserted-by":"publisher","unstructured":"Hossain MF, et al. Molecular background of Philadelphia chromosome dependent enhancement of cellular growth and tyrosine kinase inhibitor sensitivity. Exp Hematol Oncol. Feb. 2026;15(1):26. https:\/\/doi.org\/10.1186\/s40164-026-00758-4.","DOI":"10.1186\/s40164-026-00758-4"},{"key":"2303_CR154","doi-asserted-by":"publisher","unstructured":"Blasco RB, et al. Simple and Rapid In Vivo Generation of Chromosomal Rearrangements using CRISPR\/Cas9 Technology. Cell Rep. Nov. 2014;9(4):1219\u201327. https:\/\/doi.org\/10.1016\/j.celrep.2014.10.051.","DOI":"10.1016\/j.celrep.2014.10.051"},{"key":"2303_CR155","doi-asserted-by":"publisher","unstructured":"Zeisig BB, So CWE. MLL-AF4, a double-edged sword for iPSC respecification into HSPCs. Proc Natl Acad Sci U S A. Feb. 2018;115(9):1964\u20136. https:\/\/doi.org\/10.1073\/pnas.1800622115.","DOI":"10.1073\/pnas.1800622115"},{"key":"2303_CR156","doi-asserted-by":"publisher","unstructured":"Yang N, et al. Clinicopathological study of pseudomyogenic hemangioendothelioma. Diagn Pathol. Feb. 2023;18:25. https:\/\/doi.org\/10.1186\/s13000-023-01309-9.","DOI":"10.1186\/s13000-023-01309-9"},{"key":"2303_CR157","doi-asserted-by":"publisher","unstructured":"Ren J et al. Dec., A novel SERPINE1-FOSB fusion gene in pseudomyogenic hemangioendothelioma results in activation of intact FOSB and the PI3K-AKT-mTOR signaling pathway and responsiveness to sirolimus, J Dermatol, vol. 48, no. 12, pp. 1900\u20131906, 2021, https:\/\/doi.org\/10.1111\/1346-8138.16158","DOI":"10.1111\/1346-8138.16158"},{"key":"2303_CR158","doi-asserted-by":"publisher","unstructured":"Ong SLM, Baelde HJ, van IJzendoorn DGP, Bov\u00e9e JVMG, Szuhai K. Identification of stable housekeeping genes for induced pluripotent stem cells and -derived endothelial cells for drug testing. Sci Rep. Sep. 2022;12:16160. https:\/\/doi.org\/10.1038\/s41598-022-20435-w.","DOI":"10.1038\/s41598-022-20435-w"},{"key":"2303_CR159","doi-asserted-by":"publisher","unstructured":"Rowe RG, Daley GQ. Induced pluripotent stem cells in disease modelling and drug discovery, Nat Rev Genet, vol. 20, no. 7, pp. 377\u2013388, Jul. 2019, https:\/\/doi.org\/10.1038\/s41576-019-0100-z","DOI":"10.1038\/s41576-019-0100-z"},{"key":"2303_CR160","doi-asserted-by":"publisher","unstructured":"Jin M-Z, Han R-R, Qiu G-Z, Ju X-C, Lou G, Jin W-L. Organoids: An intermediate modeling platform in precision oncology. Cancer Lett. Feb. 2018;414:174\u201380. https:\/\/doi.org\/10.1016\/j.canlet.2017.11.021.","DOI":"10.1016\/j.canlet.2017.11.021"},{"issue":"4","key":"2303_CR161","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s40259-017-0234-5","volume":"31","author":"MF Naso","year":"2017","unstructured":"Naso MF, Tomkowicz B, Perry WL, Strohl WR. Adeno-Associated Virus (AAV) as a Vector for Gene Therapy. BioDrugs. 2017;31(4):317\u201334. https:\/\/doi.org\/10.1007\/s40259-017-0234-5.","journal-title":"BioDrugs"},{"key":"2303_CR162","doi-asserted-by":"publisher","unstructured":"Gaj T, Sirk SJ, Shui S, Liu J. Genome-Editing Technologies: Principles and Applications. Cold Spring Harb Perspect Biol. Dec. 2016;8(12):a023754. https:\/\/doi.org\/10.1101\/cshperspect.a023754.","DOI":"10.1101\/cshperspect.a023754"},{"key":"2303_CR163","doi-asserted-by":"publisher","unstructured":"Khoury JD, the World Health Organization Classification of Haematolymphoid Tumours. The 5th edition of : Myeloid and Histiocytic\/Dendritic Neoplasms, Leukemia, vol. 36, no. 7, pp. 1703\u20131719, Jul. 2022, https:\/\/doi.org\/10.1038\/s41375-022-01613-1","DOI":"10.1038\/s41375-022-01613-1"},{"key":"2303_CR164","doi-asserted-by":"publisher","unstructured":"Schnittger S, Weisser M, Schoch C, Hiddemann W, Haferlach T, Kern W. New score predicting for prognosis in PML-RARA+, AML1-ETO+, or CBFBMYH11\u2009+\u2009acute myeloid leukemia based on quantification of fusion transcripts, Blood, vol. 102, no. 8, pp. 2746\u20132755, Oct. 2003, https:\/\/doi.org\/10.1182\/blood-2003-03-0880","DOI":"10.1182\/blood-2003-03-0880"},{"key":"2303_CR165","doi-asserted-by":"publisher","unstructured":"Weng W et al. Oct., A scoring system based on fusion genes to predict treatment outcomes of the non-acute promyelocytic leukemia pediatric acute myeloid leukemia, Front. Med., vol. 10, 2023, https:\/\/doi.org\/10.3389\/fmed.2023.1258038","DOI":"10.3389\/fmed.2023.1258038"},{"issue":"12","key":"2303_CR166","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1111\/j.1349-7006.2008.00972.x","volume":"99","author":"H Mano","year":"2008","unstructured":"Mano H. Non-solid oncogenes in solid tumors: EML4\u2013ALK fusion genes in lung cancer. Cancer Sci. 2008;99(12):2349\u201355. https:\/\/doi.org\/10.1111\/j.1349-7006.2008.00972.x.","journal-title":"Cancer Sci"},{"issue":"5","key":"2303_CR167","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1111\/bju.12120","volume":"111","author":"D Hossain","year":"2013","unstructured":"Hossain D, Bostwick DG. Significance of the TMPRSS2:ERG gene fusion in prostate cancer. BJU Int. 2013;111(5):834\u20135. https:\/\/doi.org\/10.1111\/bju.12120.","journal-title":"BJU Int"},{"key":"2303_CR168","doi-asserted-by":"publisher","unstructured":"Xu S-M, Cheng Y, Fisher H, Janitz M. Recent advances in the investigation of fusion RNAs and their role in molecular pathology of cancer. Int J Biochem Cell Biol. Mar. 2024;168:106529. https:\/\/doi.org\/10.1016\/j.biocel.2024.106529.","DOI":"10.1016\/j.biocel.2024.106529"},{"key":"2303_CR169","doi-asserted-by":"publisher","unstructured":"Shinmura K et al. Jul., CD44-SLC1A2 fusion transcripts in primary colorectal cancer, Pathol Oncol Res, vol. 21, no. 3, pp. 759\u2013764, 2015, https:\/\/doi.org\/10.1007\/s12253-014-9887-2","DOI":"10.1007\/s12253-014-9887-2"},{"key":"2303_CR170","doi-asserted-by":"publisher","unstructured":"Tao J et al. Apr., CD44-SLC1A2 gene fusions in gastric cancer, Sci Transl Med, vol. 3, no. 77, p. 77ra30, 2011, https:\/\/doi.org\/10.1126\/scitranslmed.3001423","DOI":"10.1126\/scitranslmed.3001423"},{"key":"2303_CR171","doi-asserted-by":"publisher","unstructured":"S\u00e1nchez-Mar\u00edn D, Silva-C\u00e1zares MB, Gonz\u00e1lez-Del M, Carmen, Campos-Parra AD. Drug repositioning in thyroid cancer: from point mutations to gene fusions. Front Oncol. May 2024;14:1407511. https:\/\/doi.org\/10.3389\/fonc.2024.1407511.","DOI":"10.3389\/fonc.2024.1407511"},{"key":"2303_CR172","doi-asserted-by":"publisher","unstructured":"Mullighan CG, et al. Deletion of IKZF1 and Prognosis in Acute Lymphoblastic Leukemia. N Engl J Med. Jan. 2009;360(5):470\u201380. https:\/\/doi.org\/10.1056\/NEJMoa0808253.","DOI":"10.1056\/NEJMoa0808253"},{"key":"2303_CR173","doi-asserted-by":"publisher","unstructured":"Stanulla M et al. Apr., IKZF1plus Defines a New Minimal Residual Disease-Dependent Very-Poor Prognostic Profile in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia, J Clin Oncol, vol. 36, no. 12, pp. 1240\u20131249, 2018, https:\/\/doi.org\/10.1200\/JCO.2017.74.3617","DOI":"10.1200\/JCO.2017.74.3617"},{"key":"2303_CR174","doi-asserted-by":"publisher","unstructured":"Sch\u00e4fer D, et al. 5% of healthy newborns have an ETV6-RUNX1 fusion as revealed by DNA-based GIPFEL screening. Blood. Feb. 2018;131(7):821\u20136. https:\/\/doi.org\/10.1182\/blood-2017-09-808402.","DOI":"10.1182\/blood-2017-09-808402"},{"issue":"1","key":"2303_CR175","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s10555-019-09841-1","volume":"39","author":"D Hein","year":"2020","unstructured":"Hein D, Borkhardt A, Fischer U. Insights into the prenatal origin of childhood acute lymphoblastic leukemia. Cancer Metastasis Rev. 2020;39(1):161\u201371. https:\/\/doi.org\/10.1007\/s10555-019-09841-1.","journal-title":"Cancer Metastasis Rev"},{"key":"2303_CR176","doi-asserted-by":"publisher","unstructured":"Bueno C et al. Sep., Natural history and cell of origin of TCF3-ZNF384 and PTPN11 mutations in monozygotic twins with concordant BCP-ALL, Blood, vol. 134, no. 11, pp. 900\u2013905, 2019, https:\/\/doi.org\/10.1182\/blood.2019000893","DOI":"10.1182\/blood.2019000893"},{"key":"2303_CR177","doi-asserted-by":"publisher","unstructured":"Gover-Proaktor A, et al. Bosutinib, dasatinib, imatinib, nilotinib, and ponatinib differentially affect the vascular molecular pathways and functionality of human endothelial cells. Leuk Lymphoma. Jan. 2019;60(1):189\u201399. https:\/\/doi.org\/10.1080\/10428194.2018.1466294.","DOI":"10.1080\/10428194.2018.1466294"},{"key":"2303_CR178","doi-asserted-by":"publisher","unstructured":"Hughes TP et al. Dec., Asciminib in Chronic Myeloid Leukemia after ABL Kinase Inhibitor Failure, New England Journal of Medicine, vol. 381, no. 24, pp. 2315\u20132326, 2019, https:\/\/doi.org\/10.1056\/NEJMoa1902328","DOI":"10.1056\/NEJMoa1902328"},{"key":"2303_CR179","doi-asserted-by":"publisher","unstructured":"Druker BJ et al. Dec., Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia, N Engl J Med, vol. 355, no. 23, pp. 2408\u20132417, 2006, https:\/\/doi.org\/10.1056\/NEJMoa062867","DOI":"10.1056\/NEJMoa062867"},{"key":"2303_CR180","doi-asserted-by":"publisher","unstructured":"Bose P, Park H, Al-Khafaji J, Grant S. Strategies to circumvent the T315I gatekeeper mutation in the Bcr-Abl tyrosine kinase, Leuk Res Rep, vol. 2, no. 1, pp. 18\u201320, Mar. 2013, https:\/\/doi.org\/10.1016\/j.lrr.2013.02.001","DOI":"10.1016\/j.lrr.2013.02.001"},{"key":"2303_CR181","doi-asserted-by":"publisher","unstructured":"Childress MA, Himmelberg SM, Chen H, Deng W, Davies MA, Lovly CM. ALK Fusion Partners Impact Response to ALK Inhibition: Differential Effects on Sensitivity, Cellular Phenotypes, and Biochemical Properties, Mol Cancer Res, vol. 16, no. 11, pp. 1724\u20131736, Nov. 2018, https:\/\/doi.org\/10.1158\/1541-7786.MCR-18-0171","DOI":"10.1158\/1541-7786.MCR-18-0171"},{"key":"2303_CR182","doi-asserted-by":"publisher","unstructured":"Xie J, Gao Y, Xu W, Zhu J. Mechanisms of Resistance to ALK Inhibitors and Corresponding Treatment Strategies in Lung Cancer. Int J Gen Med. Apr. 2025;18:2151\u201371. https:\/\/doi.org\/10.2147\/IJGM.S512395.","DOI":"10.2147\/IJGM.S512395"},{"key":"2303_CR183","doi-asserted-by":"publisher","unstructured":"Gautschi O, et al. Selpercatinib in RET Fusion-Positive Non-Small Cell Lung Cancer: Final Safety and Efficacy, Including Overall Survival, From the LIBRETTO-001 Phase I\/II Trial. J Clin Oncol. May 2025;43(15):1758\u201364. https:\/\/doi.org\/10.1200\/JCO-24-02076.","DOI":"10.1200\/JCO-24-02076"},{"key":"2303_CR184","doi-asserted-by":"publisher","unstructured":"Drilon A, et al. Efficacy of Larotrectinib in TRK Fusion\u2013Positive Cancers in Adults and Children. N Engl J Med. Feb. 2018;378:731\u20139. https:\/\/doi.org\/10.1056\/NEJMoa1714448.","DOI":"10.1056\/NEJMoa1714448"},{"key":"2303_CR185","doi-asserted-by":"publisher","unstructured":"Sulakhe D et al. Jun., Exploring the functional impact of alternative splicing on human protein isoforms using available annotation sources, Brief Bioinform, vol. 20, no. 5, pp. 1754\u20131768, 2019, https:\/\/doi.org\/10.1093\/bib\/bby047","DOI":"10.1093\/bib\/bby047"},{"key":"2303_CR186","doi-asserted-by":"publisher","unstructured":"Tan X, Wang P, Li Y, Yuan B, Sun Q, Liu Y. Long-Read Sequencing Reveals RNA Splicing Complexity in Human Diseases. Comput Struct Biotechnol J, 35, 1, p. 0052, https:\/\/doi.org\/10.34133\/csbj.0052","DOI":"10.34133\/csbj.0052"},{"key":"2303_CR187","doi-asserted-by":"publisher","unstructured":"Sakamoto KM, Kim KB, Kumagai A, Mercurio F, Crews CM, Deshaies RJ. Protacs: Chimeric molecules that target proteins to the Skp1\u2013Cullin\u2013F box complex for ubiquitination and degradation, Proceedings of the National Academy of Sciences, vol. 98, no. 15, pp. 8554\u20138559, Jul. 2001, https:\/\/doi.org\/10.1073\/pnas.141230798","DOI":"10.1073\/pnas.141230798"},{"key":"2303_CR188","doi-asserted-by":"publisher","unstructured":"Fan G et al. Oct., Proteolysis-Targeting Chimera (PROTAC): Current Applications and Future Directions, MedComm (2020), vol. 6, no. 10, p. e70401, 2025, https:\/\/doi.org\/10.1002\/mco2.70401","DOI":"10.1002\/mco2.70401"},{"key":"2303_CR189","doi-asserted-by":"publisher","unstructured":"Singh A, Tekade M, Nagaraja S, Bharti A, Tekade RK. Advancements in RNA-based therapies from bench to bedside. npj Drug Discov. Feb. 2026;3(1). https:\/\/doi.org\/10.1038\/s44386-025-00037-y.","DOI":"10.1038\/s44386-025-00037-y"},{"key":"2303_CR190","doi-asserted-by":"publisher","unstructured":"Rehman SU, et al. Recent insights into the functions and mechanisms of antisense RNA: emerging applications in cancer therapy and precision medicine. Front Chem. Jan. 2024;11:1335330. https:\/\/doi.org\/10.3389\/fchem.2023.1335330.","DOI":"10.3389\/fchem.2023.1335330"},{"key":"2303_CR191","doi-asserted-by":"publisher","unstructured":"Yang W, et al. Immunogenic neoantigens derived from gene fusions stimulate T cell responses. Nat Med. May 2019;25(5):767\u201375. https:\/\/doi.org\/10.1038\/s41591-019-0434-2.","DOI":"10.1038\/s41591-019-0434-2"},{"key":"2303_CR192","doi-asserted-by":"publisher","unstructured":"McGranahan N, et al. Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade. Science. Mar. 2016;351(6280):1463\u20139. https:\/\/doi.org\/10.1126\/science.aaf1490.","DOI":"10.1126\/science.aaf1490"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-026-02303-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-026-02303-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-026-02303-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T08:47:09Z","timestamp":1788166029000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-026-02303-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,31]]},"references-count":192,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2303"],"URL":"https:\/\/doi.org\/10.1007\/s10238-026-02303-3","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,31]]},"assertion":[{"value":"15 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"312"}}